Tag: Neothetics

All

The lipodissolving injectable category amps up as Neothetics’ tummy tamer enters Phase 3 trials. Stay tuned.

Incyte’s sNDA for ruxolitinib cream in children ages 2–11 now faces a new action date to allow additional data review.